KCM
LLY icon

Kames Capital Management’s Eli Lilly LLY Stock Holding History

Kames Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-23,857
Closed -$1.55M – 171
2014
Q3 		$1.55M Sell
23,857
-19,255
-45% -$1.22M 0.05% 125
2014
Q2 		$2.68M Buy
+43,112
New +$2.57M 0.09% 93
2013
Q3 		– Sell
-29,874
Closed -$1.47M – 172
2013
Q2 		$1.47M Buy
+29,874
New +$1.63M 0.05% 128

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Kames Capital Management's LLY Position: Q4 2014 in Review

Kames Capital Management sold out of Eli Lilly (LLY) in Q4 2014, closing a stake of 23,857 shares — an estimated $1.55M sold.

Kames Capital Management first reported a position in LLY in Q2 2013 and held it in 3 quarters. The position peaked at $2.68M in Q2 2014. 1,129 funds tracked by Wall St. Rank hold LLY as of Q4 2014.

  • Kames Capital Management reported no remaining Eli Lilly position as of Q4 2014 after selling out during the quarter.
  • Kames Capital Management sold 23,857 Eli Lilly shares in Q4 2014, an estimated $1.55M.
  • Kames Capital Management first reported a position in Eli Lilly in Q2 2013 and held it in 3 quarters.
  • Kames Capital Management's Eli Lilly position peaked at $2.68M in Q2 2014.
  • 1,129 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2014.

Based on Kames Capital Management's 13F filing for Q4 2014, filed 3 Feb 2015.